SCHEMBL28809309

SCHEMBL28809309

C[C@@H]1CN(C(=O)O)[C@@H](C)CN1c1cccc2cccnc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
HCRTR1 O43613 2/20 0.42
HCRTR2 O43614 2/20 0.42
TSHR P16473 2/20 0.41
ESR2 Q92731 1/20 0.41
TRPV1 Q8NER1 1/20 0.41
GFER P55789 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
SLC6A4 P31645 1/20 0.40
MAPT P10636 3/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
THRB P10828 1/20 0.39
HTT P42858 2/20 0.39
KDM4E B2RXH2 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ALOX15 P16050 1/20 0.38
PARP1 P09874 1/20 0.38
HRH3 Q9Y5N1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23602021 0.84 KDM4E (0.48) ALDH1A1HCRTR1HCRTR2TSHRESR2
SCHEMBL31336130 0.84 KDM4E (0.48) ALDH1A1HCRTR1HCRTR2TSHRESR2
SCHEMBL29764171 0.84 KDM4E (0.48) ALDH1A1HCRTR1HCRTR2TSHRESR2
SCHEMBL6483851 0.76 TLR8 (0.45)
SCHEMBL23578715 0.73 HTR2A (0.46) ALDH1A1TSHRESR2GFERHTR2A
SCHEMBL6971671 0.71 HTR2A (0.45) ALDH1A1TSHRTRPV1HTR2AHTR2C
SCHEMBL26086786 0.70 HCRTR2 (0.43) ALDH1A1HCRTR1HCRTR2TSHRKDM4E
SCHEMBL26089752 0.70 HCRTR2 (0.43) ALDH1A1HCRTR1HCRTR2TSHRKDM4E
SCHEMBL23602022 0.69 MAP4K4 (0.53) HCRTR1HCRTR2TRPV1HTR2AHTR2C
SCHEMBL26088631 0.68 HCAR2 (0.68) ALDH1A1HCRTR1HCRTR2MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114846015-A Substituted heteroaryl compounds useful as T cell activators 百时美施贵宝公司 2022-08-02 CN disclosed